Tudor Investment Corp
HRMY icon

Tudor Investment Corp’s Harmony Biosciences HRMY Stock Holding History

Tudor Investment Corp’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
38,534
+9,732
+34% +$319K ﹤0.01% 2318
2025
Q4 		$1.08M Buy
+28,802
New +$947K ﹤0.01% 2218
2024
Q1 		– Sell
-32,273
Closed -$1.04M – 2448
2023
Q4 		$1.04M Buy
+32,273
New +$901K 0.01% 1422
2023
Q3 		– Sell
-30,142
Closed -$1.06M – 2532
2023
Q2 		$1.06M Buy
30,142
+371
+1% +$12.8K 0.01% 1286
2023
Q1 		$972K Buy
+29,771
New +$1.36M 0.02% 1224
2020
Q4 		– Sell
-6,236
Closed -$211K – 1448
2020
Q3 		$211K Buy
+6,236
New +$227K 0.01% 1124

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Tudor Investment Corp's HRMY Position: Q1 2026 in Review

Tudor Investment Corp increased its Harmony Biosciences (HRMY) stake by 34% in Q1 2026, buying an estimated $319K and bringing the position to 38,534 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Tudor Investment Corp first reported a position in HRMY in Q3 2020 and has held it in 6 quarters since. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Tudor Investment Corp held 38,534 shares of Harmony Biosciences worth $1.08M as of Q1 2026.
  • Tudor Investment Corp bought 9,732 Harmony Biosciences shares in Q1 2026, an estimated $319K.
  • Harmony Biosciences made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2318 holding.
  • Tudor Investment Corp first reported a position in Harmony Biosciences in Q3 2020 and has held it in 6 quarters since.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.